Poly Medicure Limited — Investor Meet, 01-10-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Poly Medicure has acquired Citieffe, an Italian trauma and extremity specialist, marking its entry into orthopedics. Citieffe reported 2024 revenue of EUR 17.3 million (15% YoY growth) and EBITDA of EUR 3.1 million (14% YoY growth), with robust gross margins exceeding 90%. The acquisition values Citieffe at an enterprise value of EUR 31 million, approximately 10x its 2024 EBITDA. Management sees key synergies in expanding Citieffe’s product portfolio with 'plates,' growing its US market presence, and exploring manufacturing or distribution opportunities in India. Citieffe’s Bologna facility has sufficient capacity to double revenue within five years with minimal additional capital expenditure. This strategic move positions Poly Medicure in a high-growth medical device segment.